Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Completed 5Terminated 2Recruiting 2Unknown 1

Sponsor Class

OTHER 3NIH 1NETWORK 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Endocrine 5Genitourinary 1

Conditions

Adrenocortical Carcinoma 5

Interventions

Everolimus 32Octreotide 15Cisplatin 14pasireotide 13Sunitinib 13Temozolomide 11pembrolizumab 10Etoposide 10Doxorubicin 10lanreotide 9Magnetic Resonance Spectroscopy 9Bevacizumab 9lutetium Lu 177 dotatate 8gallium Ga 68 dotatate 8Sorafenib 8Paclitaxel 83-Iodobenzylguanidine 8lenvatinib 7pazopanib 6Radiotherapy 6Positron Emission Tomography Computed Tomography 6surufatinib 5cabozantinib 5avelumab 5Thyrotropin Alfa 5Surgical Procedures, Operative 5Radiosurgery 5Nivolumab 5Mitotane 5Irinotecan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Mitotane × Endocrine × Clear all
NCT03723941 2024-08-01

ACACIA

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 3 Completed
40 enrolled
Endocrine

Adrenocortical Carcinoma

NCT00304070 2024-02-28

Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor

Children's Oncology Group

Phase 3 Completed
78 enrolled 15 charts
Endocrine

Adrenocortical Carcinoma

NCT05344027 2023-03-08

MitoS-FP

King's College Hospital NHS Trust

Completed
35 enrolled
Endocrine

Adrenocortical Carcinoma

NCT00094497 2016-09-21

Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)

Collaborative Group for Adrenocortical Carcinoma Treatment

Phase 3 Completed
304 enrolled 12 charts
Endocrine

Adrenocortical Carcinoma

NCT00001339 2008-03-04

A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
42 enrolled
Endocrine

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡